US2014343140A1PendingUtilityA1
Agent for Preventing and/or Treating Veisalgia
Est. expiryDec 7, 2031(~5.4 yrs left)· nominal 20-yr term from priority
A61P 43/00A61P 39/02A61P 3/00A61P 25/32A61K 31/315A61K 31/295A61K 33/30A61K 31/525A61K 33/26A61K 31/197A61K 31/198A61K 31/194A61P 1/16A61K 33/04A61K 9/48C07C 229/22A61K 33/24
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
[Problem] To provide an agent for preventing and/or treating veisalgia. [Solution] Provided is an agent for preventing and/or treating veisalgia, the agent including an ALA (5-aminolevulinic acid).
Claims
exact text as granted — not AI-modified1 . A hangover prophylactic and/or therapeutic agent comprising a compound shown below (Formula I):
R 1 —NHCH 2 COCH 2 CH 2 COOR 2 (Formula I) or a salt thereof, wherein R 1 represents a hydrogen atom or an acyl group, and R 2 represents a hydrogen atom, a linear or branched alkyl group, a cycloalkyl group, an aryl group, or an aralkyl group).
2 . The hangover prophylactic and/or therapeutic agent according to claim 1 , wherein
R 1 is selected from the group consisting of a hydrogen atom, an alkanoyl group having 1-8 carbons, and an aroyl group having 7-14 carbons, and R 2 is selected from the group consisting of a hydrogen atom, a linear or branched alkyl group having 1-8 carbons, a cycloalkyl group having 3-8 carbons, an aryl group having 6-14 carbons, and an aralkyl group having 7-15 carbons.
3 . The hangover prophylactic and/or therapeutic agent according to claim 1 , wherein
R 1 is selected from the group consisting of a hydrogen atom, a formyl group, an acetyl group, a propionyl group, and a butyryl group, and R 2 is selected from the group consisting of a hydrogen atom, a methyl group, an ethyl group, a propyl group, a butyl group, and a pentyl group.
4 . The hangover prophylactic and/or therapeutic agent according to claim 1 , wherein
R 1 is a hydrogen atom, and R 2 is selected from the group consisting of a hydrogen atom, a methyl group, an ethyl group, a propyl group, a butyl group, and a pentyl group.
5 . The hangover prophylactic and/or therapeutic agent according to claim 1 , wherein
R 1 is a hydrogen atom, and R 2 is a hydrogen atom.
6 . The hangover prophylactic and/or therapeutic agent according to claim 1 , wherein said prophylactic and/or therapeutic agent further contains one or two or more types of metals.
7 . The hangover prophylactic and/or therapeutic agent according to claim 6 , wherein said metal is selected from the group consisting of iron, magnesium, zinc, nickel, vanadium, copper, chromium, molybdenum, and cobalt.
8 . The hangover prophylactic and/or therapeutic agent according to claim 7 , wherein said metal is selected from the group consisting of iron, magnesium, and zinc.
9 . The hangover prophylactic and/or therapeutic agent according to claim 8 , characterized in that said metal is iron.
10 . The hangover prophylactic and/or therapeutic agent according to claim 9 , wherein said iron is sodium ferrous citrate.Join the waitlist — get patent alerts
Track US2014343140A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.